Sanofi-aventis (SNY) and Regeneron Pharma Announce Phase 3 VELOUR Will Complete Without Modification

September 8, 2010 4:18 PM EDT Send to a Friend
Sanofi-aventis (NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (Nasdaq ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login